XHKG
0297
Market cap1.09bUSD
Oct 09, Last price
1.24HKD
1D
1.64%
1Q
-0.80%
Jan 2017
18.10%
Name
Sinofert Holdings Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Sinofert Holdings Limited, an investment holding company, engages in the production, import and export, distribution, and retail of fertilizer raw materials and crop nutrition products in Mainland China and internationally. The company operates through Basic Business, Growth Business, and Production segments. It offers potash, phosphate, bio-compound, special, and nitrogen fertilizers; sulfur, crop protection, and seeds; and monocalcium and dicalcium phosphate. The company also provides technological research and development, and services relating to crop nutrition business and products; trades in fertilizers; develops agriculture products; and manufactures and sells feeds. In addition, it explores for and exploits a phosphate mine. The company was founded in 1993 and is based in Wan Chai, Hong Kong. Sinofert Holdings Limited operates as a subsidiary of Syngenta Group (Hk) Holdings Company Limited.
Key people
Fu Su
Non-Executive Chairman of the Board · since 2024
Guangzhu Shi
Deputy Chief Executive Officer, QHSE Director
Ling Wang
Chief Financial Officer, Executive Director · since 2023
Shengnan Chen
Deputy General Manager, Executive Director · since 2024
Fang Wang
Deputy General Manager · since 2020
Tielin Wang
Chief Executive Officer, Executive Director · since 2024
Guangyang Zhang
Non-Executive Director · since 2025
Independent Non-Executive Director · since 2000
Xin Lu
Independent Non-Executive Director · since 2015
Independent Non-Executive Director · since 2024
Legal address
c/o CODAN SERVICES LIMITED, Clarendon House, 2 Church Street
Hamilton HM 11
BM
Hamilton HM 11
BM
Headquarters
Units 4705, 47th Floor, Office Tower, Convention Plaza1 Harbour Road, Wanchai
Hong Kong
HK
Hong Kong
HK
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||